{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:00:51Z","timestamp":1779883251847,"version":"3.53.1"},"reference-count":86,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">UV<\/jats:styled-content> radiation exposure is the major contributor to photocarcinogenesis and photoageing. Reducing <jats:styled-content style=\"fixed-case\">UV<\/jats:styled-content> radiation exposure can be achieved by using adequate sunscreen preparations. The use of sunscreen can significantly reduce the incidence of squamous cell carcinoma, actinic keratoses and invasive melanoma. In the Australian market over 900 sunscreen products are available, each with their own brand, formulation and ingredients. It can be difficult for dermatologists and consumers to determine which are the most effective and appropriate products to use. We discuss the specific active ingredients found in sunscreen formulations available in Australia, their mode of protection, photostability, solubility, and side\u2010effects and the methods used by the Therapeutic Goods Administration to determine the ratings and efficacy of each sunscreen.<\/jats:p>","DOI":"10.1111\/ajd.12597","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T16:04:04Z","timestamp":1489161844000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Active sunscreen ingredients in Australia"],"prefix":"10.1111","volume":"58","author":[{"given":"Francis HX","family":"Yap","sequence":"first","affiliation":[{"name":"Department of Dermatology Royal Perth Hospital Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hock C","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Dermatology Fiona Stanley Hospital Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare P","family":"Tait","sequence":"additional","affiliation":[{"name":"Department of Dermatology Royal Perth Hospital Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12109"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5934"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.7078"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2008.00365.x"},{"key":"e_1_2_15_6_1","volume-title":"Sunscreen Standard AS\/NZS 2604:2012 Regulation Impact Statement","author":"Therapeutic Goods Administration Department of Health and Ageing","year":"2013"},{"key":"e_1_2_15_7_1","volume-title":"Sunscreen Products \u2013 Evaluation and Classification. AS\/NZS 2604:2012","author":"Australia\/New Zealand Standard","year":"2012"},{"key":"e_1_2_15_8_1","unstructured":"Therapeutic Goods Administration.Australian regulatory guidelines for sunscreens.2016. Available from URL:https:\/\/www.tga.gov.au\/publication\/australian-regulatory-guidelines-sunscreens-args. (Accessed 17 November 2016.)"},{"key":"e_1_2_15_9_1","unstructured":"NSAI Standards.Cosmetics \u2013 sun protection test methods \u2013 in vivo determination of the sun protection factor (SPF) (ISO 2444:2010).2010. Available from URL:http:\/\/www.iso.org\/iso\/catalogue_detail.htm?csnumber=46523. (Accessed 22 November 2016)."},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2002.00768.x"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1992.tb03263.x"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2009.00450.x"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2130.2004.00107.x"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.02.029"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2008.00379.x"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2010.00856.x"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1979.tb07090.x"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000280561.02915.3a"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2001.017001002.x"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10225.x"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2494.2009.00542.x"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.07.043"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.005"},{"key":"e_1_2_15_24_1","first-page":"209","article-title":"The effect of solvents on the ultraviolet absorbance of sunscreens","volume":"38","author":"Agrapidis\u2010Paloympis LE","year":"1987","journal-title":"J. Soc. Cosmet. Chem."},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2494.2008.00417.x"},{"key":"e_1_2_15_26_1","unstructured":"BASF Aktiengesellschaft Fine Chemicals Europe.Uvinul T\u2010Lite and Z cote grades UV absorbers for cosmetic products BASF technical information. Available from URL:http:\/\/www.rumapel.com.ar\/cosmetica_uv\/ficha_tecnica\/UVINUL%20GRADES%20-%20Z%20COTE.pdf. (Accessed 22 November 2016.)"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12344991"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.223644"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07007.x"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01017.x"},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-2494.2001.00089.x"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1562\/0031-8655(2001)074<0401:POBMAA>2.0.CO;2"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2012.068"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-2494.2002.00137.x"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.2165\/11537050-000000000-00000"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-407691-4.00003-4"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/php.12117"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-2494.2001.00071.x"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22741"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2013.814062"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00056.x"},{"key":"e_1_2_15_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2012.01280.x"},{"key":"e_1_2_15_43_1","first-page":"34","article-title":"Evaluation of sunscreen safety by in vitro skin permeation studies: effects of vehicle composition","volume":"68","author":"Montenegro L","year":"2013","journal-title":"Pharmazie"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02492.x"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581803022S303"},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460514.x"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70532-3"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kft187"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2494.2010.00598.x"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2000.99237.x"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30094-9"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10857.x"},{"key":"e_1_2_15_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12205"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e31827edc8b"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-8977-10-15"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12417"},{"key":"e_1_2_15_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07458.x"},{"key":"e_1_2_15_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12145"},{"key":"e_1_2_15_59_1","unstructured":"NganV.Irritant contact dermatitis. DermNet NZ.2015. Available from URL:http:\/\/dermnetnz.org\/dermatitis\/contact-irritant.html. (Accessed 19 November 2016.)"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91277-0"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb00227.x"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.01109239"},{"key":"e_1_2_15_63_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9369"},{"key":"e_1_2_15_64_1","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research (CDER).Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Pharmacology and Toxicology.2005. Available from URL:http:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm078932.pdf. (Accessed 22 November 2016.)"},{"key":"e_1_2_15_65_1","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, dog, monkey and man","volume":"50","author":"Freireich EJ","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"e_1_2_15_66_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.10983"},{"key":"e_1_2_15_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/es204415a"},{"key":"e_1_2_15_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287390590895054"},{"key":"e_1_2_15_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfg102"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2006.01.002"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-011-5141-x"},{"key":"e_1_2_15_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2006.07.014"},{"key":"e_1_2_15_73_1","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2001.1511"},{"key":"e_1_2_15_74_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/198789"},{"key":"e_1_2_15_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2013.05.004"},{"key":"e_1_2_15_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408440601177780"},{"key":"e_1_2_15_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/17435390903502028"},{"key":"e_1_2_15_78_1","doi-asserted-by":"publisher","DOI":"10.3762\/bjnano.5.245"},{"key":"e_1_2_15_79_1","volume-title":"Opinion on Titanium Dioxide (Nano Form)","author":"Scientific Committee on Consumer Safety","year":"2014"},{"key":"e_1_2_15_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq243"},{"key":"e_1_2_15_81_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn403118u"},{"key":"e_1_2_15_82_1","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2013.7177"},{"key":"e_1_2_15_83_1","doi-asserted-by":"publisher","DOI":"10.1039\/C4NR00458B"},{"key":"e_1_2_15_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(97)00068-3"},{"key":"e_1_2_15_85_1","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2010.2682"},{"key":"e_1_2_15_86_1","doi-asserted-by":"publisher","DOI":"10.1039\/C3PP50428J"},{"key":"e_1_2_15_87_1","first-page":"1","article-title":"Effects of titanium dioxide nanoparticles on human keratinocytes","volume":"40","author":"Wright C","year":"2016","journal-title":"Drug Chem. Toxicol."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajd.12597","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.12597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T04:45:58Z","timestamp":1734410758000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.12597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1111\/ajd.12597"],"URL":"https:\/\/doi.org\/10.1111\/ajd.12597","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]},"assertion":[{"value":"2016-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}